Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-type voltage-dependent calcium channels (LVDCCs) are a class of voltage-gated calcium channels. They have a complex structure composed of five subunits: α1, α2, δ, β, and γ. The α1 subunit is the core functional component containing four homologous domains, each with six transmembrane segments (S1-S6). The S1-S4 segments form the voltage sensing domain, while S5-S6 and the P-loop form the conduction pore and gating apparatus. The α1 subunit has cytosolic N and C termini, with a longer C-terminus. The auxiliary subunits (α2, δ, β, γ) modulate channel function and localization; α2 and δ are extracellular, while β and γ are cytosolic. There are four main subtypes: Cav1.1 (skeletal muscle), Cav1.2 (cardiac and smooth muscle), Cav1.3 (sinoatrial node, various tissues), and Cav1.4 (retinal cells). L-type channels are generally high voltage-activated (except Cav1.3), exhibit slower activation kinetics, rapid deactivation, weak voltage-dependent inactivation, and strong calcium-dependent inactivation. They are highly sensitive to dihydropyridine calcium channel blockers. These channels are essential for excitation-contraction coupling in various muscles, regulation of heart rhythm and development, smooth muscle contraction in blood vessels, aldosterone secretion, and signal transduction during muscle excitation-contraction coupling. The 3D structure, determined by electron cryomicroscopy, shows an asymmetrical heart-shaped and handle-shaped structure, approximately 160 × 220 Å.
L-type calcium channels are highly sensitive to and blocked by drugs like dihydropyridine calcium channel blockers, which modulate calcium influx.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-type voltage-dependent calcium channels (LVDCCs).